SI1478380T1 - Uporaba inhibitorjev tirozin kinaze za zdravljenje bolezni CZS - Google Patents

Uporaba inhibitorjev tirozin kinaze za zdravljenje bolezni CZS

Info

Publication number
SI1478380T1
SI1478380T1 SI200330427T SI200330427T SI1478380T1 SI 1478380 T1 SI1478380 T1 SI 1478380T1 SI 200330427 T SI200330427 T SI 200330427T SI 200330427 T SI200330427 T SI 200330427T SI 1478380 T1 SI1478380 T1 SI 1478380T1
Authority
SI
Slovenia
Prior art keywords
tyrosine kinase
kinase inhibitors
cns disorders
treating cns
treating
Prior art date
Application number
SI200330427T
Other languages
English (en)
Inventor
Alain Moussy
Jean-Pierre Kinet
Original Assignee
Ab Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Science filed Critical Ab Science
Priority claimed from PCT/IB2003/001425 external-priority patent/WO2003072090A2/en
Publication of SI1478380T1 publication Critical patent/SI1478380T1/sl

Links

SI200330427T 2002-02-27 2003-02-26 Uporaba inhibitorjev tirozin kinaze za zdravljenje bolezni CZS SI1478380T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35965202P 2002-02-27 2002-02-27
PCT/IB2003/001425 WO2003072090A2 (en) 2002-02-27 2003-02-26 Use of tyrosine kinase inhibitors for treating cns disorders
EP03712535A EP1478380B1 (en) 2002-02-27 2003-02-26 Use of tyrosine kinase inhibitors for treating cns disorders

Publications (1)

Publication Number Publication Date
SI1478380T1 true SI1478380T1 (sl) 2006-12-31

Family

ID=37603592

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330427T SI1478380T1 (sl) 2002-02-27 2003-02-26 Uporaba inhibitorjev tirozin kinaze za zdravljenje bolezni CZS

Country Status (1)

Country Link
SI (1) SI1478380T1 (sl)

Similar Documents

Publication Publication Date Title
AU2003206785A1 (en) Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
HK1160859A1 (en) Inhibitors of tyrosine kinases
AU2003299651A8 (en) Tyrosine kinase inhibitors
IL166625A0 (en) Combination of vegf receptor tyrosine kinase inhibitors for treatment of cancer
PL374700A1 (en) Use of cytokine synthesis inhibitors for the treatment of dry eye disorders
AU2003282891A8 (en) Novel tyrosine kinases inhibitors
PL373300A1 (en) Novel tyrosine kinase inhibitors
HUP0600103A2 (en) Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
ZA200700223B (en) Quinazolin-4-yl-piperidine and cinnolin-4-yl-peperidine derivatives as PDE10 inhibitors for the treatment of CNS disorders
HK1079426A1 (en) Use of ikappab kinase inhibitors for the treatment of pain
AU2003298942A8 (en) Tyrosine kinase inhibitors
EP1534268A4 (en) TYROSINE KINASE INHIBITORS
HK1072545A1 (en) Novel inhibitors of kinases
IL144309A0 (en) Monoamine reuptake inhibitors for treatment of cns disorders
AU2003275282A8 (en) Novel tyrosine kinase inhibitors
EP1581539A4 (en) NEW TYROSINE KINASE HEMMER
IL177320A0 (en) Inhibitors of tgf-r signaling for treatment of cns disorders
PL373835A1 (en) Use of cd23 antagonists for the treatment of neoplastic disorders
EP1390052A4 (en) INHIBITION OF JUN KINASE
EP1651599A4 (en) TYROSINE KINASE INHIBITORS
EP1496897A4 (en) INHIBITORS OF TYROSINE KINASES
SI1478380T1 (sl) Uporaba inhibitorjev tirozin kinaze za zdravljenje bolezni CZS
GB2410744B (en) Kinase inhibitors for the treatment of disease
HK1062806A1 (en) Novel methods for the treatment and prevention of pain using stress- activated protein kinase inhibitors
EP1633306A4 (en) USE OF PHOSPHATASE INHIBITORS AS ADJUNTIVE THERAPY IN PSYCHIC DISORDER